Company Filing History:
Years Active: 2017
Title: Dimosthenis Mantopoulos: Innovator in Retinal Health
Introduction
Dimosthenis Mantopoulos is a notable inventor based in Rahway, NJ, who has made significant contributions to the field of retinal health. His innovative work focuses on preserving the viability of photoreceptor cells following retinal detachment, a condition that can lead to severe vision loss.
Latest Patents
Mantopoulos holds a patent for "Methods for preserving photoreceptor cell viability following retinal detachment." This patent outlines methods for maintaining the viability of photoreceptor cells by administering a hydrophilic bile acid, such as UDCA or TUDCA, to mammals with detached retinas. The administration of these compounds helps preserve the viability of photoreceptor cells until the retina can be reattached, thereby minimizing potential vision loss.
Career Highlights
Mantopoulos is affiliated with the Massachusetts Eye and Ear Infirmary, where he continues to advance research in retinal health. His work is crucial in developing therapeutic strategies that can significantly impact patient outcomes in ophthalmology.
Collaborations
Some of his notable coworkers include Demetrios Vavvas and Joan W. Miller, who contribute to the collaborative efforts in research and innovation within the institution.
Conclusion
Dimosthenis Mantopoulos is a dedicated inventor whose work in preserving photoreceptor cell viability represents a significant advancement in the field of retinal health. His contributions are vital for improving treatment options for patients suffering from retinal detachment.